Bernard Bochner
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Bernard Bochner as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:26 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05126472 · Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard TreatmentMemorial Sloan Kettering Cancer Center · recruiting · Non-muscle Invasive Bladder Cancer · principal investigator
- Ph3NCT02908061 · A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a HerniaMemorial Sloan Kettering Cancer Center · completed · Radical Cystectomy · principal investigator
- N/ANCT00745355 · Quality of Life in Patients With Bladder CancerMemorial Sloan Kettering Cancer Center · active not recruiting · Bladder Cancer · principal investigator
- N/ANCT00612326 · Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and StagingMemorial Sloan Kettering Cancer Center · completed · Bladder Cancer, Transitional Cell Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Project 2: Developing Novel Combination Immunotherapeutics for Non–Muscle-Invasive Bladder CancerP50CA310825 · NCI · SLOAN-KETTERING INST CAN RESEARCH · fiscal years 2026 · $514,639 awarded in 2026Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:26 UTC. The ranking covers the 200 most relevant of 27 PubMed records, and a shared surname and initials can bring in a namesake. All 27 on PubMed
- Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody.J Immunol · 1997579 citationsRCR 15.0
- Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial.Eur Urol · 2015487 citationsRCR 20.7
- 307 citationsRCR 8.4
- Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes.Eur Urol · 2018200 citationsRCR 9.7
- 171 citationsRCR 4.6
- Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder.J Clin Oncol · 2006140 citationsRCR 3.7
- Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer.J Clin Oncol · 2018113 citationsRCR 3.7
- Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.J Clin Oncol · 2023105 citationsRCR 9.5
- Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge.J Allergy Clin Immunol · 201098 citationsRCR 2.9
- The relationship between serum IgE and surface levels of FcepsilonR on human leukocytes in various diseases: correlation of expression with FcepsilonRI on basophils but not on monocytes or eosinophils.J Allergy Clin Immunol · 200095 citationsRCR 2.0